EZH2 and prostate carcinoma: EZH2 can epigenetically silence the dysfunctional homology interaction protein (DAB2IP), a tumor suppressor involved in regulating Ras and NF-κB pathways, thereby driving tumorigenesis and metastasis in prostate cancer 92.